Probi and Pharmavite expand collaboration in the US and international markets

Probi and Pharmavite have signed a new long-term agreement for distribution and
marketing of Probi´s probiotic products. Under the new agreement Pharmavite will
broaden the distribution and expand the Nature Made® range with additional
probiotic products from Probi. Pharmavite will also expand it´s probiotic
business internationally, among other markets, in the Middle East.

Pharmavite launched Probi Digestis® capsules based on Probi’s flagship strain
LP299V® in the US market under the Nature Made® brand in 2012 and have accounted
for a significant portion of Probi’s growth in the US. Pharmavite and Probi have
signed a new long-term agreement under which Pharmavite will broaden the
distribution of Probi Digestis® capsules through additional sales channels on
the fast growing US market.

Probiotic products are an important part of Pharmavite’s strategic focus for the
coming year and Pharmavite will together with Probi expand it´s probiotic range
with additional products and offerings.

“We are very excited to expand our partnership with Pharmavite. Pharmavite is a
reputable and skilled partner whose quality focus is an excellent match with
Probi’s clinically proven products”, says Peter Nählstedt, CEO of Probi.

The companies have also signed an international agreement under which Pharmavite
will launch Probi Digestis® internationally on markets where Pharmavite is
currently selling the Nature Made®brand. The first international market to
launch is the United Arab Emirates and registration processes have been
initiated in multiple countries in the Middle East.

“Probiotics is an area of focus for Pharmavite and we plan to invest  in this
category going forward. Probi plays a major role in this effort as we share the
same commitment to reasearch and development and the marketing of efficacious
products”, says Etienne Patout, Chief Marketing Officer of Pharmavite.

Pharmavite operates in the self-care market and has been active in the US market
for more than 40 years. The company markets and sells vitamins, minerals,
dietary supplements (VMS) and health food products under the number 1 US VMS
broadline brand Nature Made®. Pharmavite is based in Northridge, California, and
is a subsidiary of the global pharmaceutical company Otsuka Pharmaceutical Ltd.

The digestive health capsules, marketed under the Nature Made®brand, are Probi’s
dietary supplement Probi Digestis®which are based on the company’s well
-documented probiotic strain Lactobacillus plantarum 299v (DSM 9843).

The information is such that Probi AB is required to disclose in accordance with
the Swedish Securities Market Act and/or the Financial Instruments Trading Act.

FOR MORE INFORMATION, CONTACT
Peter Nählstedt, CEO, Probi, tel +46 46 286 89 23 or mobile +46 723 86 99 83, e
-mail: peter.nahlstedt@probi.se
Niklas Bjärum, VP Marketing & Sales, Probi, tel +46 46 286 89 67 or mobile
+46 705 38 88 64, e-mail: niklas.bjarum@probi.se

ABOUT PROBI
Probi AB is a Swedish publicly traded bioengineering company that develops
effective and well-documented probiotics. Through its world-leading research,
Probi has created a strong product portfolio in the gastrointestinal health and
immune system niches. Probi’s products are available to consumers in more than
30 countries worldwide. Probi’s customers are leading food, health-product and
pharmaceutical companies in the Functional Food and Consumer Healthcare
segments. Probi had sales of MSEK 102 in 2013. The Probi share is listed on
NASDAQ OMX Stockholm, Small-cap. Probi has approximately 4,000 shareholders.
Read more on www.probi.se.